CRISPR_Logo.jpg
CRISPR Therapeutics to Present at the Stifel 2016 Healthcare Conference
November 08, 2016 08:00 ET | CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR_Logo.jpg
CRISPR Therapeutics Announces Pricing of Initial Public Offering
October 18, 2016 21:59 ET | CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq:CRSP), a biopharmaceutical company focused on translating CRISPR/Cas9 gene-editing...
Poseida.jpg
Poseida Therapeutics Establishes Scientific Advisory Board
September 08, 2016 07:30 ET | Poseida Therapeutics, Inc.
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...
Poseida.jpg
Poseida Therapeutics Expands Executive Leadership Team
August 18, 2016 07:30 ET | Poseida Therapeutics, Inc.
SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics,...